Impact of estrogen replacement on ventricular myocyte contractile function and protein kinase B/Akt activation

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 284, Issue 5 53-5, 2003, Pages

  Ren, Jun ^a   Hintz, Kadon K ^b   Roughead, Z K Fariba ^c   Duan, Jinhong ^a   Colligan, Peter B ^b   Ren, Bonnie H ^a   Lee, Kap J ^b   Zeng, Huawei ^c  

^a UNIVERSITY OF WYOMING COLLEGE OF HEALTH SCIENCES   (United States)

^b UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

Cardiac myocyte; Contraction; Intracellular Ca2+; Ovariectomy

Indexed keywords

ADENOSINE TRIPHOSPHATASE INHIBITOR; CALCIUM; ESTROGEN; FULVESTRANT; FURA 2; PHOSPHOLAMBAN; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; FLUORESCENCE; HORMONE DEFICIENCY; MUSCLE CELL; MUSCLE CONTRACTILITY; NONHUMAN; OVARIECTOMY; OVARY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UTERUS WEIGHT; WEIGHT GAIN; WESTERN BLOTTING;

EID: 0345700659     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00866.2002     Document Type: Article

References (35)

1. Bers DM. Cardiac excitation-contraction coupling. Nature 415: 198-205, 2002.
2. Bowling N, Bloomquist WE, Cohen ML, Bryant HU, Cole HW, Magee DE, Rowley ER, and Vlahos CJ. Effects of prolonged ethinyl estradiol treatment on calcium channel binding and in vivo calcium-mediated hemodynamic responses in ovariectomized rats. J Pharmacol Exp Ther 281: 218-225, 1997.
3. Camper-Kirby D, Welch S, Walker A, Shiraishi I, Setchell KD, Schaefer E, Kajstura J, Anversa P, and Sussman MA. Myocardial Akt activation and gender: increased nuclear activity in females versus males. Circ Res 88: 1020-1027, 2001.
4. Capasso JM, Remily RM, Smith RH, and Sonnenblick EH. Sex differences in myocardial contractility in the rat. Basic Res Cardiol 78: 156-171, 1983.
5. Chu SC, Chou YC, Liu JY, Chen CH, Shyu JC, and Chou FP. Fluctuation of serum leptin level in rats after ovariectomy and the influence of estrogen supplement. Life Sci 64: 2299-2306, 1999.
6. Davidoff AJ and Ren J. Sex-related differences of high [glucose]-induced relaxation dysfunction in rat ventricular myocytes (Abstract). Circulation 96: 1630, 1997.
7. Enserink M. Women's health. The vanishing promises of hormone replacement. Science 297: 325-326, 2002.
8. Farhat MY, Lavigne MC, and Ramwell PW. The vascular protective effects of estrogen. FASEB J 10: 615-624, 1996.
9. Foncea R, Andersson M, Ketterman A, Blakesley V, SapagHagar M, Sugden PH, LeRoith D, and Lavandero S. Insulin-like growth factor-I rapidly activates multiple signal transduction pathways in cultured rat cardiac myocytes. J Biol Chem 272:19115-19124, 1997.
10. Grohe C, Kahlert S, Lobbert K, Stimpel M, Karas RH, Vetter H, and Neyses L. Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Lett 416: 107-112, 1997.
11. Hayward CS, Kelly RP, and Collins P. The roles of gender, the menopause and hormone replacement on cardiovascular function. Cardiovasc Res 46: 28-49, 2000.
12. Hintz KK, Wold LE, Colligan PB, Scott GI, Lee KJ, Sowers JR, and Ren J. Influence of ovariectomy on ventricular myocyte contraction in simulated diabetes. J Biomed Sci 8: 307-313, 2001.
13. Ho JE and Mosca L. Postmenopausal hormone replacement therapy and atherosclerosis. Curr Atheroscler Rep 4:387-395, 2002.
14. Koss KL, Grupp IL, and Kranias EG. The relative phospholamban and SERCA2 ratio: a critical determinant of myocardial contractility. Basic Res Cardiol 1: 17-24, 1997.
15. Lip GY, Blann AD, Jones AF, and Beevers DG. Effects of hormone-replacement therapy on hemostatic factors, lipid factors, and endothelial function in women undergoing surgical menopause: implications for prevention of atherosclerosis. Am Heart J 134: 764-771, 1997.
16. Matsui T, Tao J, del Monte F, Lee KH, Li L, Picard M, Force TL, Franke TF, Hajjar RJ, and Rosenzweig A. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 104: 330-335, 2001.
17. Mosca L, Collins P, Herrington DM, Mendelsohn ME, Pasternak RC, Robertson RM, Schenck-Gustafsson K, Smith SC Jr, Taubert KA, Wenger NK, and American Heart Association. Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 104: 499-503, 2001.
18. Muck AO, Seeger H, Korte K, and Lippert TH. Cardiovascular protection by postmenopausal estrogen replacement therapy: possible mechanisms of the estrogen action. Clin Exp Obstet Gynecol 21: 143-149, 1994.
19. Nelson HD, Humphrey LL, Nygren P, Teutsch SM, and Allan JD. Postmenopausal hormone replacement therapy: scientific review. JAMA 288: 872-881, 2002.
20. Nuedling S, Kahlert S, Loebbert K, Doevendans PA, Meyer R, Vetter H, Grohe C. 17 Beta-estradiol stimulates expression of endothelial and inducible NO synthase in rat myocardium in-vitro and in-vivo. Cardiovasc Res 43: 666-674, 1999.
21. Patterson E, Ma LM, Szabo B, Robinson CP, and Thadani V. Ovariectomy and estrogen-induced alterations in myocardial contractility in female rabbits: role of the L-type calcium channel. J Pharmacol Exp Ther 284: 586-591, 1998.
22. 2+ release in cardiomyocytes. Nat Cell Biol 3: 867-873, 2001.
23. Ren J. Altered cardiac contractile responsiveness to insulin-like growth factor I in ventricular myocytes from BB spontaneous diabetic rats. Cardiovasc Res 46: 162-171, 2000.
24. Rosano GMC, Chierchia SL, Leonardo F, Beale CM, and Collins P. Cardioprotective effects of ovarian hormones. Eur Heart J 17: S15-S19, 1996.
25. Schaible TF, Malhotra A, Ciambrone G, and Scheuer J. The effects of gonadectomy on left ventricular function and cardiac contractile proteins in male and female rats. Circ Res 54: 38-49, 1984.
26. Scheuer J, Malhotra A, Schaible TF, and Capasso J. Effects of gonadectomy and hormonal replacement on rat hearts. Circ Res 61: 12-19, 1987.
27. Schillaci G, Verdecchia P, Borgioni C, Ciucci A, and Porcellati C. Early cardiac changes after menopause. Hypertension 32:764-769, 1998.
28. Simon JA, Hsia J, Cauley JA, Richards C, Harris F, Fong J, Barrett-Connor E, and Hulley SB. Postmenopausal hormone therapy and risk of stroke: the Heart and Estrogen-Progestin Replacement Study (HERS). Circulation 103: 638-642, 2001.
29. Skafar DF, Xu R, Morales JA, Ram JL, and Sowers JR. Female sex hormones and cardiovascular disease in women. J Clin Endorinol Metab 82: 3913-3918, 1997.
30. Sowers JR. Diabetes mellitus and cardiovascular disease in women. Arch Intern Med 158: 617-621, 1998.
31. Subbiah MTR. Estrogen replacement therapy and cardioprotection: mechanisms and controversies. Braz J Med Biol Res 35: 271-276, 2002.
32. Tchernof A, Calles-Escandon J, Sites CK, and Poehlman ET. Menopause, central body fatness, and insulin resistance: effects of hormone-replacement therapy. Coron Artery Dis 9: 503-511, 1998.
33. Wattanapermpool J and Reiser PJ. Differential effects of ovariectomy on calcium activation of cardiac and soleus myofilaments. Am J Physiol Heart Circ Physiol 277: H467-H473, 1999.
34. Wenger NK. The high risk of CHD for women: understanding why prevention is crucial (Abstract). Medscape Womens Health 1: 6, 1996.
35. Wold LE, Relling DP, Duan J, Norby FL, and Ren J. Abrogated leptin-induced cardiac contractile response in ventricular myocytes under spontaneous hypertension: role of Jak/STAT pathway. Hypertension 39: 69-74, 2002.